1623 Capital’s PolyPid PYPD Stock Holding History

1623 Capital’s Portfolio PYPD Stock Details PYPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-388	Closed	-$90K	–	70
2021 Q3	$90K	Hold	388	–	–	0.04%	74
2021 Q2	$105K	Buy	388 +87	+29%	+$24.2K	0.04%	71
2021 Q1	$83K	Buy	+301	New	+$98.1K	0.03%	72

Other funds holding PYPD

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

1623 Capital's PYPD Position: Q4 2021 in Review

1623 Capital sold out of PolyPid (PYPD) in Q4 2021, closing a stake of 388 shares — an estimated $90K sold.

1623 Capital first reported a position in PYPD in Q1 2021 and held it in 3 quarters. The position peaked at $105K in Q2 2021. 27 funds tracked by Wall St. Rank hold PYPD as of Q4 2021.

1623 Capital reported no remaining PolyPid position as of Q4 2021 after selling out during the quarter.
1623 Capital sold 388 PolyPid shares in Q4 2021, an estimated $90K.
1623 Capital first reported a position in PolyPid in Q1 2021 and held it in 3 quarters.
1623 Capital's PolyPid position peaked at $105K in Q2 2021.
27 funds tracked by Wall St. Rank held PolyPid as of Q4 2021.

Based on 1623 Capital's 13F filing for Q4 2021, filed 11 Feb 2022.